Molecular Templates Inc’s filing revealed that its 10% Owner BIOTECH TARGET N V unloaded Company’s shares for reported $0.85 million on Nov 14 ’24. In the deal valued at $0.66 per share,1,279,820 shares were sold. As a result of this transaction, BIOTECH TARGET N V now holds 0 shares worth roughly $0.0.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Then, BIOTECH TARGET N V bought 250,000 shares, generating $587,500 in total proceeds. Upon buying the shares at $2.35, the 10% Owner now owns 1,279,820 shares.
BofA Securities initiated its Molecular Templates Inc [MTEM] rating to a Buy in a research note published on April 21, 2021; the price target was $12. A number of analysts have revised their coverage, including UBS’s analysts, who began to cover the stock in early February with a ‘”a Neutral”‘ rating. Jefferies began covering MTEM with “Buy” recommendation on September 08, 2020. Stifel started covering the stock on March 25, 2020. It rated MTEM as “a Buy”.
Price Performance Review of MTEM
On Monday, Molecular Templates Inc [NASDAQ:MTEM] saw its stock jump 19.77% to $0.40. Over the last five days, the stock has lost -11.29%. Molecular Templates Inc shares have fallen nearly -89.23% since the year began. Nevertheless, the stocks have fallen -91.70% over the past one year. While a 52-week high of $5.37 was reached on 03/04/24, a 52-week low of $0.29 was recorded on 10/14/24. SMA at 50 days reached $0.8229, while 200 days put it at $1.5720.
Levels Of Support And Resistance For MTEM Stock
The 24-hour chart illustrates a support level at 0.3428, which if violated will result in even more drops to 0.2840. On the upside, there is a resistance level at 0.4502. A further resistance level may holdings at 0.4988. The Relative Strength Index (RSI) on the 14-day chart is 41.76, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.0284, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 89.94%. Stochastics %K at 6.45% indicates the stock is a buying.
How much short interest is there in Molecular Templates Inc?
A steep rise in short interest was recorded in Molecular Templates Inc stocks on 2024-10-31, growing by 0.13 million shares to a total of 0.27 million shares. Yahoo Finance data shows the prior-month short interest on 2024-09-30 was 0.14 million shares. There was a rise of 47.49%, which implies that there is a positive sentiment for the stock.
The most recent change occurred on February 27, 2020 when Barclays began covering the stock and recommended ‘”an Overweight”‘ rating along with a $22 price target.
